VentureBeat April 1, 2020
Dean Takahashi

The world has been shaken up by the coronavirus, and the global startup community is no exception. Startup Genome has issued the first installment of reports that it plans to do on how startups are being affected since the onset of COVID-19.

The company found that Chinese venture capital deals fell 50 to 57 percentage points in the first two months of the year, since the onset of the crisis, relative to the rest of the world. If a drop like that happens globally, even for just two months, approximately $28 billion in startup investment will go missing in 2020, with a dramatic impact on companies, based on extrapolations of data collected by Pitchbook and Startup Genome.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Technology, Trends
Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform
Podcast: The State of Antitrust & Private Equity in Health Care w/ Brent Fulton
Metsera lands with $290m to take on obesity giants
Private equity bankruptcies in healthcare explode 112% in 5 years
California’s AB 3129: A New Hurdle for Private Equity Health Care Transactions on the Horizon?

Share This Article